Alpha-methyldopa-induced immune thrombocytopenia. Report of case.
The clinical and laboratory features of a case of alphamethyldopa-induced thrombocytopenia are described. This is the second reported case in which the presence of alpha-methyldopa-induced platelet antibodies have been demonstrated.
D058186:Acute Kidney Injury / Q000150:complications; D000917:Antibody Formation; D001014:Aortic Aneurysm / Q000150:complications; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000032:analysis / Q000276:immunology; D003298:Coombs Test; D005260:Female; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000188:drug therapy; D008750:Methyldopa / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D013921:Thrombocytopenia / Q000139:chemically induced* / Q000276:immunology; D013925:Thromboplastin / Q000032:analysis
D008750:Methyldopa; D013925:Thromboplastin